Beijing Hotgen Biotech Co Ltd Class A 688068
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.95
- Dividend Yield (Trailing)
- 0.75%
- Dividend Yield (Forward)
- 0.75%
- Total Yield
- 0.75%
Company Profile
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,036
- Website
- http://www.hotgen.com.cn
Comparables
Valuation
|
Metric
|
688068
|
688253
|
603392
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.62 | 85.49 |
Price/Book Value | 0.77 | 2.70 | 7.57 |
Price/Sales | 4.95 | 8.00 | 34.36 |
Price/Cash Flow | — | 15.34 | 402.76 |
Price/Earnings
688068
688253
603392
Financial Strength
|
Metric
|
688068
|
688253
|
603392
|
|---|---|---|---|
Quick Ratio | 3.29 | 15.40 | 3.81 |
Current Ratio | 6.88 | 15.84 | 4.48 |
Interest Coverage | −253.76 | 2,238.82 | −59.06 |
Quick Ratio
688068
688253
603392
Profitability
|
Metric
|
688068
|
688253
|
603392
|
|---|---|---|---|
Return on Assets (Normalized) | −5.33% | 12.17% | −3.06% |
Return on Equity (Normalized) | −5.67% | 13.13% | −3.76% |
Return on Invested Capital (Normalized) | −6.61% | 12.68% | −4.05% |
Return on Assets
688068
688253
603392
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Zlltxslbc | Htlpz | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Fvflyhlx | Pvcstbv | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Hhkrctfh | Smdgyvq | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Vhfphdzly | Wqwlcp | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Bswbmhlt | Vnq | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Qjymwcnr | Ndhp | $28.1 Bil | |||
| Moderna Inc
MRNA
| Nmnqcgvx | Zlgzz | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Mcsmtmmm | Dpqf | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Gvbydtqg | Xkrrp | $13.4 Bil | |||
| Incyte Corp
INCY
| Jccdvdy | Ybqshv | $12.7 Bil |
United States